LYEL- Lyell Immunopharma, Inc.

Name: Lyell Immunopharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lyell Immunopharma, Inc. (LYEL) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. LYEL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Shah Smital	140.0K	$2.71M	-
Dir	Klausner Richard	130.0K	$2.51M	-
Dir	Rieflin William Jl	130.0K	$2.51M	-
Dir	Brawley Otis W	130.0K	$2.51M	-
Dir	Friedman Cathy	130.0K	$2.51M	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 10, 2025	Lee Gary K.	Chief Scientific Officer	Sell	138	$16.16	$2,230.08	-0.9%	+31.5%	-
Nov 10, 2025	Hill Stephen J.	Chief Operating Officer	Sell	95	$16.12	$1,531.40	-0.6%	+31.5%	-
Aug 21, 2025	Newton Charles W.66	Chief Financial Officer	Sell	1,453	$10.54	$15,320.43	-8.7%	+61.7%	-
Aug 21, 2025	Lee Gary K.	Chief Scientific Officer	Sell	1,453	$10.54	$15,320.43	-8.6%	+61.7%	-
Aug 21, 2025	Seely Lynn65	President And CEO	Sell	7,257	$10.54	$76,517.81	-9.7%	+61.7%	-
Aug 21, 2025	Hill Stephen J.	Chief Operating Officer	Sell	1,004	$10.54	$10,586.18	-6.0%	+61.7%	-
Aug 12, 2025	Hill Stephen J.	Chief Operating Officer	Sell	185	$10.43	$1,929.64	-1.0%	+67.3%	-
Aug 12, 2025	Seely Lynn65	President And CEO	Sell	797	$10.43	$8,312.89	-1.1%	+67.3%	-
Aug 12, 2025	Lee Gary K.	Chief Scientific Officer	Sell	267	$10.43	$2,784.87	-1.5%	+67.3%	-
Aug 12, 2025	Newton Charles W.66	Chief Financial Officer	Sell	267	$10.43	$2,784.87	-1.5%	+67.3%	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC